To identify aberrantly spliced transcripts associated with SF3B1, SRSF2, and U2AF1 mutations in MDS hematopoietic stem and progenitor cells, Pellagatti and colleagues performed RNA-seq on CD34+ cells from 82 patients with MDS and 8 healthy control individuals [188]. This evidence concerns the gene SRSF2 and myelodysplastic syndrome.